Shanghai Fosun Pharmaceutical OTC Market: SFOSF
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a healthcare company, engages in the research, development, manufacture, trade, and sale of pharmaceutical products
Name | Shanghai Fosun Pharmaceutical |
Ticker | SFOSF |
Exchange | OTC Market |
Sector | Health Care |
Industry | Drug Manufacturers - Diversified |
Price | 4.88 |
52W Low/High | 2.37 / 5.23 |
Market cap | - |
1Y Total Return |
77.64%
Strong |
1Y Volatility |
64.99%
More Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a healthcare company, engages in the research, development, manufacture, trade, and sale of pharmaceutical products
Details
Ticker | SFOSF |
Name | Shanghai Fosun Pharmaceutical |
ISIN | |
CUSIP | |
Exchange | OTC Market |
Sector | Health Care |
Industry | Drug Manufacturers - Diversified |
Country | China |
Currency | U.S. Dollar |
Share as of 1/25/21
Close Price | 4.88 |
52W Low/High | 2.37 / 5.23 |
Market cap | - |
1Y Total Return |
77.64%
Strong |
1Y Volatility |
64.99%
More Risk |
Beta | 0.70 |
PE (trailing) | - |
12M Dividends | - |
Last Dividend Date | 6/14/16 |
Dividend Yield | - |
Fin. Strength
Net Profit Margin | - |
Cash from Op. / Cur. Liabilities | - |
Diluted Earnings / Share | - |
ROE | - |
ROIC | - |
Price / Revenue | - |
Price / Book | - |
Price / CF | - |
Current Ratio | - |
Cur.Liabilities / Tot.Liabilities | - |
Financial Leverage | - |
No quarterly accounting data available at the moment
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available